Company news
Renerve Limited news in 2025
Renerve Limited's news releases, calls and decks from 2025, newest first.
ReNerve AGM Presentation
November 26, 2025
ReNerve completes $3.2m capital raising
November 19, 2025
Trading Halt
November 17, 2025
Nerve Cuff approved for use in US DoD and VA hospitals
November 12, 2025
ReNerve Clinical Study Expansion
November 4, 2025
Q1 FY26 Activities Report and Appendix 4C
October 22, 2025
ReNerve achieves first sales of amniotic tissue range
October 13, 2025
Investor Roadshow Presentation
September 28, 2025
Empliq Product Launch
September 22, 2025
ReNerve launches the EmpliQ product ranges
September 22, 2025
ReNerve - Appendix 4E
August 28, 2025
ReNerve records first sale of deep dermal product range
August 17, 2025
Q4 FY25 Activities Report and Appendix 4C
July 30, 2025
Expands Product Portfolio with Berkley partnership / Webinar
June 1, 2025
ReNerve receives market approval in Bahrain
May 28, 2025
ReNerve - Q3 FY25 Activities Report & Appendix 4C
April 29, 2025
Expands Global Footprint with Strategic Partnership in India
April 9, 2025
Response to ASX Aware Letter
March 31, 2025
Clinical Outcome Demonstrates Material Benefits for Patients
March 27, 2025
1HFY25 Results Announcement
February 27, 2025
1HFY25 Appendix 4D and Half Year Report
February 27, 2025
ReNerve - Q2 FY25 Activities Report & Appendix 4C
January 28, 2025
Decks in 2025
- Shareholder Meeting (November 2025)
Shareholder meeting · 21 slides · Nov 27, 2025
- Earnings Presentation (November 2025)
Earnings · 21 slides · Nov 10, 2025
- Non-Deal Roadshow (September 2025)
Roadshow · 28 slides · Sep 29, 2025
- Earnings Presentation (August 2025)
Earnings · 15 slides · Aug 12, 2025
- Investor Presentation (June 2025)
Investor deck · 15 slides · Jun 3, 2025
- Q3 FY25 Earnings Presentation
Earnings · 19 slides · May 7, 2025
- Q2 FY25 Earnings Presentation
Earnings · 14 slides · Feb 6, 2025